{"id":"NCT01455597","sponsor":"Warner Chilcott","briefTitle":"Evaluate Long-Term Safety and Efficacy WC3011 (Estradiol Vaginal Cream)","officialTitle":"A Multicenter, Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of WC3011 (Estradiol Vaginal Cream) in the Treatment of Symptoms of Vulvovaginal Atrophy in Postmenopausal Women","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-10-20","primaryCompletion":"2012-12-03","completion":"2012-12-03","firstPosted":"2011-10-20","resultsPosted":"2022-05-09","lastUpdate":"2022-05-09"},"enrollment":309,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Vulvovaginal Atrophy"],"interventions":[{"type":"DRUG","name":"WC3011 Estradiol Vaginal Cream","otherNames":[]}],"arms":[{"label":"WC3011 Estradiol Vaginal Cream","type":"EXPERIMENTAL"}],"summary":"This is an open-label extension study evaluating the long-term safety and efficacy of WC3011 in non-hysterectomized, healthy, postmenopausal women with vulvovaginal atrophy.","primaryOutcome":{"measure":"Number of Participants With Endometrial Biopsy Results at Final Visit","timeFrame":"Final Visit (Day closest to Day 281)","effectByArm":[{"arm":"WC3011 Estradiol Vaginal Cream: Less Than 92 Days","deltaMin":3,"sd":null},{"arm":"WC3011 Estradiol Vaginal Cream: 92-182 Days","deltaMin":10,"sd":null},{"arm":"WC3011 Estradiol Vaginal Cream: 183-273 Days","deltaMin":7,"sd":null},{"arm":"WC3011 Estradiol Vaginal Cream: More Than 273 Days","deltaMin":166,"sd":null}],"pValues":[]},"eligibility":{"minAge":"35 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":6},"locations":{"siteCount":64,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":8,"n":308},"commonTop":["Vulvovaginal Mycotic Infection","Upper Respiratory Tract Infection","Sinusitis"]}}